Tate Michael Truett 4

What Happened Tate Michael Truett, Chief Financial Officer of Astera Labs, was granted 11,787 restricted stock units (RSUs) on February 6, 2026. The award was reported at $0.00 per share (typical for RSU grants) and therefore has no immediate cash purchase price. The RSUs represent a contingent right to receive one share of Astera Labs common stock per RSU upon vesting.

Key Details

• Transaction type: Award/Grant (Code A) — 11,787 RSUs granted on 2026-02-06 at $0.00.
• Vesting: 25% vests on February 15, 2027; remaining RSUs vest in 12 equal quarterly installments thereafter, subject to continued service (footnote F1).
• Ownership disclosure: filing includes a trust disclosure (Tate 1997 Living Trust) and a disclaimer of beneficial ownership to the extent noted (footnote F2).
• Shares owned after the transaction: not specified in the Form 4 filing.
• Filing date: Form 4 filed February 10, 2026, reporting the February 6 grant.

Context RSUs are compensation awards that convert to shares only if and when they vest; they are not an open-market purchase or sale and do not indicate an immediate cash investment or disposition. The trust disclosure notes some shares are held in the Tate 1997 Living Trust and the Reporting Person disclaims beneficial ownership of trust-held securities except for any pecuniary interest.